

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 5.97690622 |
| 2 | sodium ion export (GO:0071436) | 4.46317743 |
| 3 | negative regulation of cell size (GO:0045792) | 4.03096696 |
| 4 | regulation of cholesterol homeostasis (GO:2000188) | 3.97703422 |
| 5 | amyloid precursor protein catabolic process (GO:0042987) | 3.95980162 |
| 6 | positive regulation of histone deacetylation (GO:0031065) | 3.92728602 |
| 7 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.85997495 |
| 8 | proline biosynthetic process (GO:0006561) | 3.82743496 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 3.77560705 |
| 10 | COPI coating of Golgi vesicle (GO:0048205) | 3.77560705 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 3.64486711 |
| 12 | regulation of metalloenzyme activity (GO:0048552) | 3.59771543 |
| 13 | NADH metabolic process (GO:0006734) | 3.58721529 |
| 14 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.54119062 |
| 15 | GDP-mannose metabolic process (GO:0019673) | 3.51850075 |
| 16 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.39570084 |
| 17 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.32615276 |
| 18 | apoptotic cell clearance (GO:0043277) | 3.32274295 |
| 19 | mannose metabolic process (GO:0006013) | 3.29742650 |
| 20 | COPII vesicle coating (GO:0048208) | 3.28521379 |
| 21 | regulation of extracellular matrix disassembly (GO:0010715) | 3.28030232 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.24942965 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.24942965 |
| 24 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.24803319 |
| 25 | desmosome organization (GO:0002934) | 3.23543362 |
| 26 | positive regulation of nuclease activity (GO:0032075) | 3.20452797 |
| 27 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.19213274 |
| 28 | peptidyl-lysine dimethylation (GO:0018027) | 3.16818253 |
| 29 | regulation of translational fidelity (GO:0006450) | 3.16665306 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.16305243 |
| 31 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.12281741 |
| 32 | type B pancreatic cell proliferation (GO:0044342) | 3.11580903 |
| 33 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.10675153 |
| 34 | pentose-phosphate shunt (GO:0006098) | 3.09382619 |
| 35 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.08944844 |
| 36 | amyloid precursor protein metabolic process (GO:0042982) | 3.08442286 |
| 37 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.07013605 |
| 38 | mitotic nuclear envelope reassembly (GO:0007084) | 3.05246295 |
| 39 | nuclear envelope reassembly (GO:0031468) | 3.05246295 |
| 40 | regulation of podosome assembly (GO:0071801) | 2.96016791 |
| 41 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.94501940 |
| 42 | 4-hydroxyproline metabolic process (GO:0019471) | 2.93045267 |
| 43 | protein carboxylation (GO:0018214) | 2.91429356 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.91429356 |
| 45 | gluconeogenesis (GO:0006094) | 2.90350914 |
| 46 | hyaluronan catabolic process (GO:0030214) | 2.88287830 |
| 47 | monosaccharide biosynthetic process (GO:0046364) | 2.85851861 |
| 48 | keratan sulfate catabolic process (GO:0042340) | 2.84432607 |
| 49 | maternal placenta development (GO:0001893) | 2.84325924 |
| 50 | pinocytosis (GO:0006907) | 2.82780225 |
| 51 | cellular copper ion homeostasis (GO:0006878) | 2.82688499 |
| 52 | regulation of nuclease activity (GO:0032069) | 2.82483076 |
| 53 | extracellular fibril organization (GO:0043206) | 2.80657423 |
| 54 | hexose biosynthetic process (GO:0019319) | 2.80598909 |
| 55 | receptor catabolic process (GO:0032801) | 2.77965271 |
| 56 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.75921914 |
| 57 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.75430130 |
| 58 | barbed-end actin filament capping (GO:0051016) | 2.75336553 |
| 59 | proline metabolic process (GO:0006560) | 2.74854503 |
| 60 | apoptotic process involved in morphogenesis (GO:0060561) | 2.74823079 |
| 61 | oxaloacetate metabolic process (GO:0006107) | 2.74491416 |
| 62 | cellular potassium ion homeostasis (GO:0030007) | 2.73815390 |
| 63 | epithelial cell-cell adhesion (GO:0090136) | 2.73530341 |
| 64 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.73475358 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.72462004 |
| 66 | tricarboxylic acid cycle (GO:0006099) | 2.71997342 |
| 67 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.71726302 |
| 68 | galactose catabolic process (GO:0019388) | 2.71014397 |
| 69 | stress fiber assembly (GO:0043149) | 2.70606558 |
| 70 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.70193412 |
| 71 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.69987805 |
| 72 | peptidyl-asparagine modification (GO:0018196) | 2.67476362 |
| 73 | regulation of hippo signaling (GO:0035330) | 2.67414346 |
| 74 | membrane protein ectodomain proteolysis (GO:0006509) | 2.66515052 |
| 75 | NADPH regeneration (GO:0006740) | 2.66196901 |
| 76 | L-serine transport (GO:0015825) | 2.65189512 |
| 77 | lysine catabolic process (GO:0006554) | 2.65115189 |
| 78 | lysine metabolic process (GO:0006553) | 2.65115189 |
| 79 | cell adhesion mediated by integrin (GO:0033627) | 2.64893316 |
| 80 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64484284 |
| 81 | protein N-linked glycosylation (GO:0006487) | 2.63847975 |
| 82 | basement membrane organization (GO:0071711) | 2.63713254 |
| 83 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.63512792 |
| 84 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.63237644 |
| 85 | positive regulation of actin filament depolymerization (GO:0030836) | 2.61649300 |
| 86 | negative regulation of fatty acid transport (GO:2000192) | 2.60724467 |
| 87 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.60459491 |
| 88 | glucose 6-phosphate metabolic process (GO:0051156) | 2.59915434 |
| 89 | negative regulation of lipid transport (GO:0032369) | 2.59608646 |
| 90 | maintenance of protein localization in organelle (GO:0072595) | 2.59574039 |
| 91 | cellular sodium ion homeostasis (GO:0006883) | 2.58938234 |
| 92 | adherens junction assembly (GO:0034333) | 2.58671194 |
| 93 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.56846874 |
| 94 | cellular response to unfolded protein (GO:0034620) | 2.56672585 |
| 95 | glial cell proliferation (GO:0014009) | 2.56639225 |
| 96 | ER-nucleus signaling pathway (GO:0006984) | 2.54862670 |
| 97 | muscle cell migration (GO:0014812) | 2.54370591 |
| 98 | glycosphingolipid catabolic process (GO:0046479) | 2.54114448 |
| 99 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.53731794 |
| 100 | UV protection (GO:0009650) | 2.50764831 |
| 101 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.50484973 |
| 102 | protein localization to endosome (GO:0036010) | 2.50240880 |
| 103 | regulation of proton transport (GO:0010155) | 2.49708769 |
| 104 | positive regulation of protein deacetylation (GO:0090312) | 2.49390762 |
| 105 | layer formation in cerebral cortex (GO:0021819) | 2.48471869 |
| 106 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.47730865 |
| 107 | actin filament depolymerization (GO:0030042) | 2.47647019 |
| 108 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.46234964 |
| 109 | fibril organization (GO:0097435) | 2.46113571 |
| 110 | hydrogen peroxide catabolic process (GO:0042744) | 2.45663608 |
| 111 | sphingolipid catabolic process (GO:0030149) | 2.45106808 |
| 112 | semaphorin-plexin signaling pathway (GO:0071526) | 2.44210016 |
| 113 | cell-substrate junction assembly (GO:0007044) | 2.43407000 |
| 114 | polarized epithelial cell differentiation (GO:0030859) | 2.42620864 |
| 115 | skin morphogenesis (GO:0043589) | 2.42031066 |
| 116 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.41888823 |
| 117 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.41417117 |
| 118 | NLS-bearing protein import into nucleus (GO:0006607) | 2.41154402 |
| 119 | glycolytic process (GO:0006096) | 2.40858987 |
| 120 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.38939795 |
| 121 | peptidyl-proline hydroxylation (GO:0019511) | 2.37394633 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 2.37295935 |
| 123 | cell communication by electrical coupling (GO:0010644) | 2.37285961 |
| 124 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.36553612 |
| 125 | regulation of early endosome to late endosome transport (GO:2000641) | 2.35765141 |
| 126 | cellular response to topologically incorrect protein (GO:0035967) | 2.35516445 |
| 127 | response to laminar fluid shear stress (GO:0034616) | 2.35345322 |
| 128 | glycolipid catabolic process (GO:0019377) | 2.34920970 |
| 129 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.34456346 |
| 130 | lipopolysaccharide metabolic process (GO:0008653) | 2.34065417 |
| 131 | fibrinolysis (GO:0042730) | 2.33700193 |
| 132 | serine transport (GO:0032329) | 2.33439869 |
| 133 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.33366732 |
| 134 | negative regulation of catenin import into nucleus (GO:0035414) | 2.33242937 |
| 135 | regulation of cholesterol storage (GO:0010885) | 2.32893557 |
| 136 | embryonic foregut morphogenesis (GO:0048617) | 2.32601549 |
| 137 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.32406425 |
| 138 | regulation of plasminogen activation (GO:0010755) | 2.32155082 |
| 139 | protein hydroxylation (GO:0018126) | 2.32037538 |
| 140 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.31854188 |
| 141 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.31668076 |
| 142 | negative regulation of sterol transport (GO:0032372) | 2.31131099 |
| 143 | negative regulation of cholesterol transport (GO:0032375) | 2.31131099 |
| 144 | cell junction maintenance (GO:0034331) | 2.30385742 |
| 145 | membrane lipid catabolic process (GO:0046466) | 2.30015557 |
| 146 | negative regulation of heart growth (GO:0061117) | 2.29834360 |
| 147 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.29834360 |
| 148 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.29776560 |
| 149 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.29674321 |
| 150 | regulation of autophagic vacuole assembly (GO:2000785) | 2.29192509 |
| 151 | cell-cell junction maintenance (GO:0045217) | 2.29177992 |
| 152 | renal system development (GO:0072001) | 2.28755070 |
| 153 | hormone catabolic process (GO:0042447) | 2.27968717 |
| 154 | vesicle coating (GO:0006901) | 2.27682458 |
| 155 | regulation of cholesterol esterification (GO:0010872) | 2.27664788 |
| 156 | growth hormone receptor signaling pathway (GO:0060396) | 2.26309707 |
| 157 | germ cell migration (GO:0008354) | 2.24544730 |
| 158 | tricarboxylic acid metabolic process (GO:0072350) | 2.23550133 |
| 159 | anatomical structure regression (GO:0060033) | 2.23353707 |
| 160 | positive regulation of glycogen metabolic process (GO:0070875) | 2.23236679 |
| 161 | alanine transport (GO:0032328) | 2.23234466 |
| 162 | establishment of apical/basal cell polarity (GO:0035089) | 2.22945106 |
| 163 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.22690577 |
| 164 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.21747817 |
| 165 | cortical actin cytoskeleton organization (GO:0030866) | 2.20988311 |
| 166 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.20036943 |
| 167 | regulation of ARF GTPase activity (GO:0032312) | 2.19595274 |
| 168 | low-density lipoprotein particle clearance (GO:0034383) | 2.18904489 |
| 169 | response to endoplasmic reticulum stress (GO:0034976) | 2.18701218 |
| 170 | glucose catabolic process (GO:0006007) | 2.17236446 |
| 171 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.16409350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.19064078 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.03951340 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.90574658 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.78129278 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.74238048 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.64271405 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.56505744 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.54031089 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52882744 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.48153467 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.43549045 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38778473 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.26195487 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24427737 |
| 15 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.20167856 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19420554 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18717327 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.15480817 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13919203 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06591526 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05842916 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.04286661 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.03611674 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00906770 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.99838995 |
| 26 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.98385120 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.98052367 |
| 28 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96233598 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94240233 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94213464 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88149980 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86728047 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.84069501 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.83149549 |
| 35 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.82520426 |
| 36 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.77163843 |
| 37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.74624430 |
| 38 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.74358994 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70634968 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69893683 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68503083 |
| 42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.68302357 |
| 43 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.67550591 |
| 44 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.67240471 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.66758185 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.63370250 |
| 47 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.61617185 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60721584 |
| 49 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.59090527 |
| 50 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.56198310 |
| 51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55089332 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53765414 |
| 53 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52926986 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.52878417 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52803241 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.51093092 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.48521716 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48154883 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48056186 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47864412 |
| 61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.47594695 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46289545 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45862937 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.44889722 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44871458 |
| 66 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43490660 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42536591 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41988721 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.41967240 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.41927062 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41567326 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41501944 |
| 73 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.40601509 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40013385 |
| 75 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38564357 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37897229 |
| 77 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37514496 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36764478 |
| 79 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.35725138 |
| 80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35245041 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34398206 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33668148 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32154416 |
| 84 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31685385 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31292165 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.31003812 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28714502 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28065362 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28052435 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27021511 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26981061 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26800140 |
| 93 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.26781111 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26726262 |
| 95 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.26105191 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.25969776 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25891233 |
| 98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25554988 |
| 99 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24810150 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24246458 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23266860 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22737738 |
| 103 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.22398547 |
| 104 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21214836 |
| 105 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.21011340 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.19189252 |
| 107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17354653 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16917789 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16901727 |
| 110 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.16488553 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.16003358 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15850062 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15258195 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13854475 |
| 115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13838502 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13122092 |
| 117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12811501 |
| 118 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.12685123 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12590071 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12590071 |
| 121 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12162133 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12018486 |
| 123 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11074059 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11071345 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10869084 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10432925 |
| 127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09950412 |
| 128 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09611247 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08617056 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07801574 |
| 131 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06050397 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05716450 |
| 133 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05178555 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04712670 |
| 135 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03740115 |
| 136 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.02695841 |
| 137 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02357095 |
| 138 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02039011 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01510065 |
| 140 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01171992 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00801058 |
| 142 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.00566192 |
| 143 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00434764 |
| 144 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00386307 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00379336 |
| 146 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00162601 |
| 147 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99039938 |
| 148 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99005121 |
| 149 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98903774 |
| 150 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98852353 |
| 151 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98802328 |
| 152 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97688047 |
| 153 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96978677 |
| 154 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96782172 |
| 155 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96727863 |
| 156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96319489 |
| 157 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.96153045 |
| 158 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95865017 |
| 159 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95865017 |
| 160 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95405344 |
| 161 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95004742 |
| 162 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94562503 |
| 163 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94470463 |
| 164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94289077 |
| 165 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93286587 |
| 166 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93283436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 5.16902520 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.46978813 |
| 3 | MP0005257_abnormal_intraocular_pressure | 3.01641368 |
| 4 | MP0008961_abnormal_basal_metabolism | 2.80573168 |
| 5 | MP0005360_urolithiasis | 2.60111753 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 2.56537620 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 2.53214048 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.44169265 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.40934579 |
| 10 | MP0009840_abnormal_foam_cell | 2.38021974 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.32649486 |
| 12 | MP0005451_abnormal_body_composition | 2.31237554 |
| 13 | MP0004858_abnormal_nervous_system | 2.26360756 |
| 14 | MP0005408_hypopigmentation | 2.11379366 |
| 15 | MP0001849_ear_inflammation | 2.10278943 |
| 16 | MP0009278_abnormal_bone_marrow | 2.09607550 |
| 17 | MP0003566_abnormal_cell_adhesion | 2.07631562 |
| 18 | MP0003303_peritoneal_inflammation | 2.02453335 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.88436609 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.84310389 |
| 21 | MP0004233_abnormal_muscle_weight | 1.84227266 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83175619 |
| 23 | MP0002089_abnormal_postnatal_growth/wei | 1.78740582 |
| 24 | MP0005165_increased_susceptibility_to | 1.78289309 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.70020312 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.67303711 |
| 27 | MP0003283_abnormal_digestive_organ | 1.61322608 |
| 28 | MP0003115_abnormal_respiratory_system | 1.58725152 |
| 29 | MP0005365_abnormal_bile_salt | 1.55700853 |
| 30 | MP0003186_abnormal_redox_activity | 1.55277949 |
| 31 | MP0008260_abnormal_autophagy | 1.54977090 |
| 32 | MP0003123_paternal_imprinting | 1.53903944 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.52640318 |
| 34 | MP0006054_spinal_hemorrhage | 1.51998443 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.51848756 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.50561749 |
| 37 | MP0003329_amyloid_beta_deposits | 1.50448541 |
| 38 | MP0005330_cardiomyopathy | 1.46379791 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.46260287 |
| 40 | MP0003045_fibrosis | 1.46070308 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.44762613 |
| 42 | MP0005083_abnormal_biliary_tract | 1.44599273 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.42477929 |
| 44 | MP0000733_abnormal_muscle_development | 1.42445336 |
| 45 | MP0001958_emphysema | 1.42068382 |
| 46 | MP0003252_abnormal_bile_duct | 1.38770401 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.36658929 |
| 48 | MP0004272_abnormal_basement_membrane | 1.36249034 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.33632612 |
| 50 | MP0002295_abnormal_pulmonary_circulatio | 1.33008509 |
| 51 | MP0001542_abnormal_bone_strength | 1.30613416 |
| 52 | MP0001661_extended_life_span | 1.27099510 |
| 53 | MP0005501_abnormal_skin_physiology | 1.27049030 |
| 54 | MP0000534_abnormal_ureter_morphology | 1.26737071 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.22445345 |
| 56 | MP0004264_abnormal_extraembryonic_tissu | 1.21043348 |
| 57 | MP0005023_abnormal_wound_healing | 1.20416269 |
| 58 | MP0003091_abnormal_cell_migration | 1.19940191 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.18387557 |
| 60 | MP0005275_abnormal_skin_tensile | 1.16850578 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.14473720 |
| 62 | MP0000604_amyloidosis | 1.14386230 |
| 63 | MP0000858_altered_metastatic_potential | 1.13680621 |
| 64 | MP0003279_aneurysm | 1.12269504 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.11819946 |
| 66 | MP0001243_abnormal_dermal_layer | 1.11559863 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.09902630 |
| 68 | MP0005503_abnormal_tendon_morphology | 1.05013780 |
| 69 | MP0001915_intracranial_hemorrhage | 1.04801108 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.03628650 |
| 71 | MP0000372_irregular_coat_pigmentation | 1.02218233 |
| 72 | MP0005508_abnormal_skeleton_morphology | 1.01800304 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.99900938 |
| 74 | MP0009053_abnormal_anal_canal | 0.99794018 |
| 75 | MP0005248_abnormal_Harderian_gland | 0.99659717 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 0.99576768 |
| 77 | MP0004197_abnormal_fetal_growth/weight/ | 0.99081577 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.98543978 |
| 79 | MP0003878_abnormal_ear_physiology | 0.98543978 |
| 80 | MP0002896_abnormal_bone_mineralization | 0.96868036 |
| 81 | MP0006082_CNS_inflammation | 0.96343561 |
| 82 | MP0005670_abnormal_white_adipose | 0.96117189 |
| 83 | MP0003075_altered_response_to | 0.94862597 |
| 84 | MP0005171_absent_coat_pigmentation | 0.94169174 |
| 85 | MP0004885_abnormal_endolymph | 0.93755300 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.93077566 |
| 87 | MP0001873_stomach_inflammation | 0.93072529 |
| 88 | MP0000609_abnormal_liver_physiology | 0.92957006 |
| 89 | MP0001881_abnormal_mammary_gland | 0.92498249 |
| 90 | MP0004947_skin_inflammation | 0.91994245 |
| 91 | MP0010630_abnormal_cardiac_muscle | 0.91123523 |
| 92 | MP0004130_abnormal_muscle_cell | 0.90639471 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89620717 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.88887561 |
| 95 | MP0000343_altered_response_to | 0.88488862 |
| 96 | MP0004087_abnormal_muscle_fiber | 0.88006655 |
| 97 | MP0000751_myopathy | 0.87351495 |
| 98 | MP0010771_integument_phenotype | 0.87108855 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.86955264 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.86761484 |
| 101 | MP0002090_abnormal_vision | 0.85900849 |
| 102 | MP0000428_abnormal_craniofacial_morphol | 0.84466419 |
| 103 | MP0009672_abnormal_birth_weight | 0.84242838 |
| 104 | MP0002697_abnormal_eye_size | 0.84237083 |
| 105 | MP0001756_abnormal_urination | 0.83544297 |
| 106 | MP0005164_abnormal_response_to | 0.81659652 |
| 107 | MP0002269_muscular_atrophy | 0.81249818 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.80916454 |
| 109 | MP0002234_abnormal_pharynx_morphology | 0.79909718 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.79300080 |
| 111 | MP0000358_abnormal_cell_content/ | 0.78788062 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.78540336 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.77581697 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.77248066 |
| 115 | MP0001853_heart_inflammation | 0.76317313 |
| 116 | MP0002925_abnormal_cardiovascular_devel | 0.76112440 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.75121102 |
| 118 | MP0005390_skeleton_phenotype | 0.74454427 |
| 119 | MP0003786_premature_aging | 0.73754351 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 0.72058787 |
| 121 | MP0000747_muscle_weakness | 0.71905451 |
| 122 | MP0010307_abnormal_tumor_latency | 0.71530334 |
| 123 | MP0008770_decreased_survivor_rate | 0.71463962 |
| 124 | MP0003942_abnormal_urinary_system | 0.71352419 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.71300011 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.71294799 |
| 127 | MP0001730_embryonic_growth_arrest | 0.71165558 |
| 128 | MP0002796_impaired_skin_barrier | 0.71066030 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 0.70764816 |
| 130 | MP0000749_muscle_degeneration | 0.70138078 |
| 131 | MP0002092_abnormal_eye_morphology | 0.69986521 |
| 132 | MP0000678_abnormal_parathyroid_gland | 0.69963720 |
| 133 | MP0000767_abnormal_smooth_muscle | 0.69654928 |
| 134 | MP0002970_abnormal_white_adipose | 0.69086947 |
| 135 | MP0003795_abnormal_bone_structure | 0.69021142 |
| 136 | MP0005220_abnormal_exocrine_pancreas | 0.68833920 |
| 137 | MP0005085_abnormal_gallbladder_physiolo | 0.67231411 |
| 138 | MP0002168_other_aberrant_phenotype | 0.66956358 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.66712911 |
| 140 | MP0005197_abnormal_uvea_morphology | 0.66100136 |
| 141 | MP0005379_endocrine/exocrine_gland_phen | 0.65179387 |
| 142 | MP0002084_abnormal_developmental_patter | 0.65166277 |
| 143 | MP0002060_abnormal_skin_morphology | 0.64539968 |
| 144 | MP0000598_abnormal_liver_morphology | 0.64033866 |
| 145 | MP0003453_abnormal_keratinocyte_physiol | 0.63475298 |
| 146 | MP0000266_abnormal_heart_morphology | 0.62186761 |
| 147 | MP0002128_abnormal_blood_circulation | 0.60226320 |
| 148 | MP0005332_abnormal_amino_acid | 0.59817201 |
| 149 | MP0005166_decreased_susceptibility_to | 0.59524301 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.59465785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vertebral compression fractures (HP:0002953) | 4.70185741 |
| 2 | Hand muscle atrophy (HP:0009130) | 3.77032433 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.71767404 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.70297103 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.70297103 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.70297103 |
| 7 | Hyperacusis (HP:0010780) | 3.60934749 |
| 8 | Distal upper limb amyotrophy (HP:0007149) | 3.59087481 |
| 9 | Upper limb amyotrophy (HP:0009129) | 3.59087481 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.51952263 |
| 11 | Shallow orbits (HP:0000586) | 3.20530672 |
| 12 | Vascular calcification (HP:0004934) | 3.15337883 |
| 13 | Cholecystitis (HP:0001082) | 3.15046074 |
| 14 | Abnormal gallbladder physiology (HP:0012438) | 3.15046074 |
| 15 | Cardiovascular calcification (HP:0011915) | 3.07015049 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.05952112 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.04236962 |
| 18 | Hypokinesia (HP:0002375) | 3.02556506 |
| 19 | Abnormality of dentin (HP:0010299) | 2.89910482 |
| 20 | Lymphangioma (HP:0100764) | 2.88964429 |
| 21 | Distal lower limb muscle weakness (HP:0009053) | 2.88094138 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 2.78847714 |
| 23 | Short nail (HP:0001799) | 2.68248270 |
| 24 | Elfin facies (HP:0004428) | 2.67722589 |
| 25 | Insomnia (HP:0100785) | 2.62702023 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57761354 |
| 27 | Aneurysm (HP:0002617) | 2.55082543 |
| 28 | Broad metatarsal (HP:0001783) | 2.54411833 |
| 29 | Bladder diverticulum (HP:0000015) | 2.53213797 |
| 30 | Abnormality of glycolysis (HP:0004366) | 2.52683911 |
| 31 | Trismus (HP:0000211) | 2.46795504 |
| 32 | Deep venous thrombosis (HP:0002625) | 2.46378362 |
| 33 | Ankle contracture (HP:0006466) | 2.45053278 |
| 34 | Macroorchidism (HP:0000053) | 2.42198934 |
| 35 | Renovascular hypertension (HP:0100817) | 2.42177347 |
| 36 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.42016861 |
| 37 | Back pain (HP:0003418) | 2.38066987 |
| 38 | Prolonged neonatal jaundice (HP:0006579) | 2.34701678 |
| 39 | Nuclear cataract (HP:0100018) | 2.32721148 |
| 40 | Generalized amyotrophy (HP:0003700) | 2.32697529 |
| 41 | Aortic aneurysm (HP:0004942) | 2.32262796 |
| 42 | Enlarged penis (HP:0000040) | 2.31645191 |
| 43 | Ulnar bowing (HP:0003031) | 2.31613034 |
| 44 | Renal duplication (HP:0000075) | 2.29959629 |
| 45 | Spinal rigidity (HP:0003306) | 2.29879712 |
| 46 | Mitral valve prolapse (HP:0001634) | 2.29825186 |
| 47 | Neoplasm of the heart (HP:0100544) | 2.27247294 |
| 48 | Pseudobulbar signs (HP:0002200) | 2.23924255 |
| 49 | Cervical subluxation (HP:0003308) | 2.22873669 |
| 50 | Glucose intolerance (HP:0000833) | 2.22603399 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.20266070 |
| 52 | Loss of speech (HP:0002371) | 2.19679173 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.18355329 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18269474 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.18269474 |
| 56 | Disproportionate tall stature (HP:0001519) | 2.17641019 |
| 57 | Osteolytic defects of the hand bones (HP:0009699) | 2.16754700 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16754700 |
| 59 | Turricephaly (HP:0000262) | 2.15985359 |
| 60 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.11511979 |
| 61 | Skin nodule (HP:0200036) | 2.11331159 |
| 62 | Abnormality of the acetabulum (HP:0003170) | 2.10811485 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10523394 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10523394 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10523394 |
| 66 | Wormian bones (HP:0002645) | 2.09509940 |
| 67 | Bowel diverticulosis (HP:0005222) | 2.08229744 |
| 68 | Thin bony cortex (HP:0002753) | 2.08133836 |
| 69 | Genu recurvatum (HP:0002816) | 2.07066342 |
| 70 | Testicular atrophy (HP:0000029) | 2.05336324 |
| 71 | Orthostatic hypotension (HP:0001278) | 2.04872822 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 2.03909917 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.03806417 |
| 74 | Short 4th metacarpal (HP:0010044) | 2.02855037 |
| 75 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.02855037 |
| 76 | Aortic dissection (HP:0002647) | 2.02643905 |
| 77 | Deviation of the hallux (HP:0010051) | 2.01578507 |
| 78 | Hallux valgus (HP:0001822) | 2.01525413 |
| 79 | Distal lower limb amyotrophy (HP:0008944) | 2.01502545 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.01260863 |
| 81 | Entropion (HP:0000621) | 2.00282596 |
| 82 | Overriding aorta (HP:0002623) | 1.98985910 |
| 83 | Joint stiffness (HP:0001387) | 1.98854594 |
| 84 | Achilles tendon contracture (HP:0001771) | 1.98597187 |
| 85 | Abnormality of carpal bone ossification (HP:0006257) | 1.97009828 |
| 86 | Dilatation of the ascending aorta (HP:0005111) | 1.96738043 |
| 87 | Elbow flexion contracture (HP:0002987) | 1.96661176 |
| 88 | Dysmetric saccades (HP:0000641) | 1.95628805 |
| 89 | Ankyloglossia (HP:0010296) | 1.93489019 |
| 90 | Long toe (HP:0010511) | 1.93129621 |
| 91 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93033938 |
| 92 | Striae distensae (HP:0001065) | 1.92429538 |
| 93 | Flat acetabular roof (HP:0003180) | 1.91771212 |
| 94 | Growth hormone excess (HP:0000845) | 1.89890988 |
| 95 | Abnormality of the 4th metacarpal (HP:0010012) | 1.89447789 |
| 96 | Rectal prolapse (HP:0002035) | 1.89081662 |
| 97 | Amyloidosis (HP:0011034) | 1.88804815 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 1.87612224 |
| 99 | Peritonitis (HP:0002586) | 1.86078149 |
| 100 | Stridor (HP:0010307) | 1.85450926 |
| 101 | Axonal loss (HP:0003447) | 1.85323279 |
| 102 | Dysostosis multiplex (HP:0000943) | 1.84837200 |
| 103 | Increased density of long bones (HP:0006392) | 1.83890985 |
| 104 | Abnormality of the umbilical cord (HP:0010881) | 1.82142050 |
| 105 | Beaking of vertebral bodies (HP:0004568) | 1.81962450 |
| 106 | Atelectasis (HP:0100750) | 1.81574754 |
| 107 | Pointed chin (HP:0000307) | 1.81465614 |
| 108 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.81203005 |
| 109 | Spastic diplegia (HP:0001264) | 1.80817236 |
| 110 | Rough bone trabeculation (HP:0100670) | 1.80520467 |
| 111 | Hyperparathyroidism (HP:0000843) | 1.80373383 |
| 112 | Atrophic scars (HP:0001075) | 1.79314352 |
| 113 | Cardiomegaly (HP:0001640) | 1.78972650 |
| 114 | Nonimmune hydrops fetalis (HP:0001790) | 1.78575478 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 1.77758370 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.77606809 |
| 117 | Myocardial infarction (HP:0001658) | 1.77119075 |
| 118 | Biconcave vertebral bodies (HP:0004586) | 1.77079579 |
| 119 | Astrocytoma (HP:0009592) | 1.74948597 |
| 120 | Abnormality of the astrocytes (HP:0100707) | 1.74948597 |
| 121 | Hypoalphalipoproteinemia (HP:0003233) | 1.73128742 |
| 122 | Bowing of the arm (HP:0006488) | 1.72274737 |
| 123 | Bowed forearm bones (HP:0003956) | 1.72274737 |
| 124 | Abnormal delivery (HP:0001787) | 1.71792166 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.71047418 |
| 126 | Congenital glaucoma (HP:0001087) | 1.70752040 |
| 127 | Blue sclerae (HP:0000592) | 1.70486693 |
| 128 | Coxa vara (HP:0002812) | 1.70012876 |
| 129 | Abnormality of oral frenula (HP:0000190) | 1.69390087 |
| 130 | Flat cornea (HP:0007720) | 1.68972074 |
| 131 | Insulin resistance (HP:0000855) | 1.68641287 |
| 132 | Cerebral inclusion bodies (HP:0100314) | 1.68571679 |
| 133 | Upper limb muscle weakness (HP:0003484) | 1.67244135 |
| 134 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.66135764 |
| 135 | Abnormality of complement system (HP:0005339) | 1.65927234 |
| 136 | Increased nuchal translucency (HP:0010880) | 1.65790910 |
| 137 | Hemiplegia (HP:0002301) | 1.65629246 |
| 138 | Abdominal distention (HP:0003270) | 1.64912188 |
| 139 | Unilateral renal agenesis (HP:0000122) | 1.64618502 |
| 140 | Follicular hyperkeratosis (HP:0007502) | 1.63882109 |
| 141 | Hypoventilation (HP:0002791) | 1.63086834 |
| 142 | Fibroma (HP:0010614) | 1.62915244 |
| 143 | Mesangial abnormality (HP:0001966) | 1.62783345 |
| 144 | Metaphyseal cupping (HP:0003021) | 1.62031325 |
| 145 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61798213 |
| 146 | Increased connective tissue (HP:0009025) | 1.61528069 |
| 147 | Gout (HP:0001997) | 1.61482614 |
| 148 | Opisthotonus (HP:0002179) | 1.60539313 |
| 149 | Mitral stenosis (HP:0001718) | 1.59467463 |
| 150 | Diminished movement (HP:0002374) | 1.57894930 |
| 151 | Interstitial pulmonary disease (HP:0006530) | 1.57826006 |
| 152 | Hypercortisolism (HP:0001578) | 1.57614872 |
| 153 | Broad face (HP:0000283) | 1.57568966 |
| 154 | Severe short stature (HP:0003510) | 1.57069780 |
| 155 | Right ventricular cardiomyopathy (HP:0011663) | 1.56841762 |
| 156 | Supranuclear gaze palsy (HP:0000605) | 1.56319933 |
| 157 | Limb-girdle muscle atrophy (HP:0003797) | 1.56253729 |
| 158 | Hamartoma of the eye (HP:0010568) | 1.55970149 |
| 159 | Buphthalmos (HP:0000557) | 1.54028079 |
| 160 | Polycythemia (HP:0001901) | 1.54005832 |
| 161 | Ependymoma (HP:0002888) | 1.52486257 |
| 162 | Subacute progressive viral hepatitis (HP:0006572) | 1.52363582 |
| 163 | Slender build (HP:0001533) | 1.50947897 |
| 164 | Ectopia lentis (HP:0001083) | 1.50772866 |
| 165 | Fragile skin (HP:0001030) | 1.49991253 |
| 166 | Frequent falls (HP:0002359) | 1.49910653 |
| 167 | Fibrous tissue neoplasm (HP:0012316) | 1.49557993 |
| 168 | Increased variability in muscle fiber diameter (HP:0003557) | 1.49216259 |
| 169 | Arterial tortuosity (HP:0005116) | 1.48613284 |
| 170 | Xanthomatosis (HP:0000991) | 1.47416276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.01451819 |
| 2 | EEF2K | 3.94608189 |
| 3 | PKN2 | 3.87299803 |
| 4 | ERN1 | 3.83463754 |
| 5 | NME2 | 3.82985082 |
| 6 | MAP3K10 | 2.97814277 |
| 7 | MST1R | 2.90421940 |
| 8 | SIK1 | 2.78953209 |
| 9 | IRAK3 | 2.75705752 |
| 10 | LIMK1 | 2.75040823 |
| 11 | ICK | 2.51067214 |
| 12 | RIPK1 | 2.48664757 |
| 13 | VRK2 | 2.28990318 |
| 14 | CDK12 | 2.23131136 |
| 15 | EIF2AK1 | 2.15464203 |
| 16 | PTK6 | 2.11253089 |
| 17 | PBK | 2.10972476 |
| 18 | MAP3K3 | 2.02642471 |
| 19 | MYLK | 2.02105198 |
| 20 | BMX | 1.82579981 |
| 21 | PIM2 | 1.81566945 |
| 22 | TTN | 1.67391514 |
| 23 | ARAF | 1.65825198 |
| 24 | EPHB1 | 1.64283734 |
| 25 | PDGFRA | 1.64277904 |
| 26 | SMG1 | 1.62475349 |
| 27 | MET | 1.58982069 |
| 28 | MAP3K12 | 1.53916059 |
| 29 | PRKD3 | 1.48184151 |
| 30 | DDR2 | 1.47269112 |
| 31 | LRRK2 | 1.44590612 |
| 32 | PAK4 | 1.42891619 |
| 33 | CAMK1G | 1.41952628 |
| 34 | FGFR4 | 1.34093864 |
| 35 | PDK2 | 1.32136545 |
| 36 | TYRO3 | 1.31860039 |
| 37 | TAOK1 | 1.31526852 |
| 38 | CAMK1D | 1.30969052 |
| 39 | LMTK2 | 1.28472941 |
| 40 | MTOR | 1.25761522 |
| 41 | ALK | 1.23971492 |
| 42 | SIK2 | 1.22232150 |
| 43 | PTK2 | 1.20940192 |
| 44 | ABL2 | 1.19099086 |
| 45 | MAP4K1 | 1.17187093 |
| 46 | SCYL2 | 1.13823695 |
| 47 | PAK6 | 1.10553278 |
| 48 | TAOK2 | 1.10479967 |
| 49 | NEK1 | 1.09194404 |
| 50 | MAP3K7 | 1.07915374 |
| 51 | MAP3K9 | 1.06832715 |
| 52 | RET | 1.04361754 |
| 53 | MST4 | 1.03941062 |
| 54 | SIK3 | 1.02507134 |
| 55 | GRK6 | 1.00208154 |
| 56 | DMPK | 0.99182094 |
| 57 | CDK8 | 0.98739536 |
| 58 | LATS1 | 0.95616229 |
| 59 | NME1 | 0.94179246 |
| 60 | DAPK1 | 0.93111652 |
| 61 | KSR2 | 0.92692677 |
| 62 | PAK2 | 0.92552928 |
| 63 | ERBB4 | 0.89746969 |
| 64 | PRKCH | 0.84760729 |
| 65 | CAMKK1 | 0.84712615 |
| 66 | STK16 | 0.84283694 |
| 67 | STK10 | 0.78679521 |
| 68 | TESK1 | 0.76151605 |
| 69 | CDK7 | 0.75724322 |
| 70 | BRSK1 | 0.75548131 |
| 71 | CDK6 | 0.75501582 |
| 72 | TBK1 | 0.75230517 |
| 73 | DYRK1B | 0.74305696 |
| 74 | NEK2 | 0.72830902 |
| 75 | FGFR1 | 0.71897992 |
| 76 | LATS2 | 0.70806615 |
| 77 | PRKCI | 0.69148719 |
| 78 | STK38 | 0.67589571 |
| 79 | MOS | 0.64851318 |
| 80 | FGFR3 | 0.64809426 |
| 81 | RPS6KA2 | 0.63721896 |
| 82 | PDGFRB | 0.63596461 |
| 83 | BUB1 | 0.62150515 |
| 84 | CAMK2D | 0.61945695 |
| 85 | SGK3 | 0.59916761 |
| 86 | CDK4 | 0.59493126 |
| 87 | BCKDK | 0.59092834 |
| 88 | RPS6KB2 | 0.58819923 |
| 89 | EPHB2 | 0.58714853 |
| 90 | CAMK2G | 0.57031698 |
| 91 | PRKG2 | 0.56301313 |
| 92 | EPHA2 | 0.56012618 |
| 93 | MUSK | 0.55041997 |
| 94 | ERBB2 | 0.55025176 |
| 95 | FER | 0.54030654 |
| 96 | EIF2AK3 | 0.53453554 |
| 97 | PRPF4B | 0.53161781 |
| 98 | ILK | 0.52531054 |
| 99 | MAPK11 | 0.52458354 |
| 100 | MARK2 | 0.51948885 |
| 101 | STK4 | 0.51629018 |
| 102 | CDC42BPA | 0.50683382 |
| 103 | MAPKAPK2 | 0.50595276 |
| 104 | DAPK3 | 0.50483159 |
| 105 | PHKG2 | 0.49581021 |
| 106 | PHKG1 | 0.49581021 |
| 107 | TESK2 | 0.49303833 |
| 108 | FGFR2 | 0.49166235 |
| 109 | DAPK2 | 0.48349085 |
| 110 | PAK1 | 0.48336783 |
| 111 | PAK3 | 0.47703159 |
| 112 | NTRK2 | 0.47677189 |
| 113 | MAP3K11 | 0.47039996 |
| 114 | TGFBR2 | 0.46776726 |
| 115 | MAPKAPK3 | 0.46739586 |
| 116 | ZAP70 | 0.46723057 |
| 117 | BRAF | 0.46386621 |
| 118 | NTRK1 | 0.46262478 |
| 119 | GSK3A | 0.46046640 |
| 120 | CSK | 0.44688935 |
| 121 | CSF1R | 0.44357906 |
| 122 | RPS6KA1 | 0.43648372 |
| 123 | PRKD1 | 0.42261715 |
| 124 | ROCK2 | 0.42203890 |
| 125 | MAP3K2 | 0.41420820 |
| 126 | MAP3K1 | 0.40168983 |
| 127 | TYK2 | 0.39722408 |
| 128 | EPHA3 | 0.39123924 |
| 129 | SRC | 0.38891073 |
| 130 | JAK1 | 0.38884332 |
| 131 | PDPK1 | 0.38379705 |
| 132 | CLK1 | 0.37237068 |
| 133 | MAP2K3 | 0.36919506 |
| 134 | JAK2 | 0.36821067 |
| 135 | PTK2B | 0.36724007 |
| 136 | KDR | 0.36630065 |
| 137 | MAP3K8 | 0.36561759 |
| 138 | CDK9 | 0.35863863 |
| 139 | PRKD2 | 0.35794417 |
| 140 | UHMK1 | 0.34880277 |
| 141 | AKT2 | 0.34704267 |
| 142 | MAP2K2 | 0.34292902 |
| 143 | TRIM28 | 0.34051415 |
| 144 | PRKAA1 | 0.33279958 |
| 145 | FLT3 | 0.32869484 |
| 146 | MATK | 0.32789553 |
| 147 | BRD4 | 0.32325084 |
| 148 | MAP2K6 | 0.31928237 |
| 149 | ROCK1 | 0.31802143 |
| 150 | HCK | 0.31651643 |
| 151 | HIPK2 | 0.30889979 |
| 152 | EGFR | 0.30644912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.97452162 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.96736109 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92661978 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.69672325 |
| 5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.23063858 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.13436892 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.05038664 |
| 8 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.02873020 |
| 9 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.95848013 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.92566928 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91507092 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.82230780 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81119108 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80917221 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.75729074 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60407590 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58706198 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.54719827 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42682308 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40268157 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37650796 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.35137674 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.34987031 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25816911 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.25140617 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24121450 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.22892342 |
| 28 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22502615 |
| 29 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.21150451 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20339078 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19567988 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18834350 |
| 33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17860260 |
| 34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17472141 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15071677 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14769082 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.13796334 |
| 38 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13796015 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.12638736 |
| 40 | Focal adhesion_Homo sapiens_hsa04510 | 1.10968406 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09379414 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07349127 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06008991 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.05018832 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04258093 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02956709 |
| 47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01867714 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.01615158 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01180468 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99933257 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 0.99345641 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97469925 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96730095 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96599123 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.93849487 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92158914 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92028082 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92022367 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91681544 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90296779 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89649743 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.89238783 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88993769 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88946003 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88053067 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85860248 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85719658 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84903849 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82996303 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82877290 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81471490 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.81188621 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80550311 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79779195 |
| 75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78693798 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78658554 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77995197 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77598435 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75617267 |
| 80 | Protein export_Homo sapiens_hsa03060 | 0.74193302 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73527923 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73366378 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72698706 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72563404 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72429390 |
| 86 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71602613 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71594531 |
| 88 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.71522973 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70910718 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70741318 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70472789 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69755577 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69373558 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68699601 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68648536 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.67501561 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67398918 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66231056 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66222660 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65760862 |
| 101 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64860003 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64844843 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64082643 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64070699 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63723425 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62336741 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62118158 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61918530 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60783638 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60546461 |
| 111 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60417127 |
| 112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59807236 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58597446 |
| 114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58426750 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58346793 |
| 116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57908333 |
| 117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57084582 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55333216 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55201755 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55182627 |
| 121 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55114662 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.54905503 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54765985 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54480450 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54425186 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.54341272 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54228919 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.54088478 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54018335 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.53184872 |
| 131 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52954624 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52459350 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51993956 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.51698501 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51367543 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49644624 |
| 137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47680709 |
| 138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44027277 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43572289 |
| 140 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43538762 |
| 141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41987744 |
| 142 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37620591 |
| 143 | DNA replication_Homo sapiens_hsa03030 | 0.34020422 |
| 144 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31793309 |
| 145 | Shigellosis_Homo sapiens_hsa05131 | 0.28828753 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28810483 |
| 147 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28720031 |
| 148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28215797 |
| 149 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26286018 |
| 150 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23389803 |
| 151 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23126233 |
| 152 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20552126 |

